Efficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials
Aim This study aimed to evaluate the efficacy and safety of bimekizumab for psoriasis. Methods The PubMed, Web of Science, Cochrane Library, and Embase databases were systematically searched until November 20, 2022, to identify randomized controlled trials (RCTs) reporting the efficacy and safety of...
Saved in:
Main Authors: | Yuanyuan Qiu (Author), Yang Zhu (Author), Yun Liu (Author), Qiliang Liu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials
by: Yuqian Wang, et al.
Published: (2023) -
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
by: Joshua Burshtein, et al.
Published: (2024) -
Review of bimekizumab in the treatment of psoriasis
by: Sindhuja Koppu, et al.
Published: (2022) -
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis
by: Richard B. Warren, et al.
Published: (2024) -
Bimekizumab: the new drug in the biologics armamentarium for psoriasis
by: Egídio Freitas, et al.
Published: (2021)